Schedule 13G ownership disclosure
ACELRX PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00444T100
Event date: 2017-07-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-265672
- Form type
- SC 13G
- Filer
- TALPHERA, INC.
- CIK
- CIK 1427925
- Filed
- Aug 23, 2017
- Reporting period
- Jul 17, 2017
- Description
- Schedule 13G beneficial ownership